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Malaria over-diagnosis in Cameroon:
diagnostic accuracy of Fluorescence and
Staining Technologies (FAST) Malaria Stain
and LED microscopy versus Giemsa and
bright field microscopy validated by
polymerase chain reaction
Sean M. Parsel1,10*, Steven A. Gustafson1, Edward Friedlander1, Alexander A. Shnyra2, Aderosoye J. Adegbulu3,
Ying Liu4, Nicole M. Parrish5, Syed A. Jamal6, Eve Lofthus7, Leo Ayuk8, Charles Awasom8, Carolyn J. Henry9
and Carole P. McArthur7

Abstract
Background: Malaria is a major world health issue and its continued burden is due, in part, to difficulties in the
diagnosis of the illness. The World Health Organization recommends confirmatory testing using microscopy-based
techniques or rapid diagnostic tests (RDT) for all cases of suspected malaria. In regions where Plasmodium species
are indigenous, there are multiple etiologies of fever leading to misdiagnoses, especially in populations where HIV
is prevalent and children. To determine the frequency of malaria infection in febrile patients over an 8-month period at
the Regional Hospital in Bamenda, Cameroon, we evaluated the clinical efficacy of the Flourescence and Staining
Technology (FAST) Malaria stain and ParaLens AdvanceTM microscopy system (FM) and compared it with conventional
bright field microscopy and Giemsa stain (GS).
Methods: Peripheral blood samples from 522 patients with a clinical diagnosis of “suspected malaria” were evaluated
using GS and FM methods. A nested PCR assay was the gold standard to compare the two methods. PCR positivity,
sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were determined.
Results: Four hundred ninety nine samples were included in the final analysis. Of these, 30 were positive via PCR
(6.01%) with a mean PPV of 19.62% and 27.99% for GS and FM, respectively. The mean NPV was 95.01% and 95.
28% for GS and FM, respectively. Sensitivity was 26.67% in both groups and specificity was 92.78% and 96.21% for
GS and FM, respectively. An increased level of diagnostic discrepancy was observed between technicians based
upon skill level using GS, which was not seen with FM.
(Continued on next page)
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Conclusions: The frequency of malarial infections confirmed via PCR among patients presenting with fever and
other symptoms of malaria was dramatically lower than that anticipated based upon physicians’ clinical suspicions. A
correlation between technician skill and accuracy of malaria diagnosis using GS was observed that was less pronounced
using FM. Additionally, FM increased the specificity and improved the PPV, suggesting this relatively low cost approach
could be useful in resource-limited environments. Anecdotally, physicians were reluctant to not treat all patients
symptomatically before results were known and in spite of a negative microscopic diagnosis, highlighting the
need for further physician education to avoid this practice of overtreatment. A larger study in an area with a
known high prevalence is being planned to compare the two microscopy methods against available RDTs.
Keywords: Malaria, Fluorescent microscopy, Giemsa, Diagnostic accuracy

Multilingual abstracts
Please see Additional file 1 for translations of the abstract
into the five official working languages of the United
Nations.
Background
Malaria is an ongoing threat to world health, leading to
over 600 000 deaths each year despite increasing awareness and public health efforts directed at controlling the
disease. In Cameroon, malaria is perennial, rainfalldependent and the prevalence is 42.5% in children under
5 years of age, 31.5% in those between 5 and 15 years of
age, and 10.5% in those older than 15 years. It causes 50%
morbidity in children under 5 years old, and is implicated
in 40% to 50% of medical consultations [1]. The predominant species in the region is Plasmodium falciparum [2].
Early diagnosis with reliable microscopic confirmation
and effective treatment is paramount in reducing morbidity and mortality [3]. While malaria is a preventable disease, there are seemingly insurmountable issues with
proper diagnosis and treatment throughout endemic regions, leading to its continued prevalence and increasing
drug resistance. Due to inadequate resources, inexperienced technical personnel, poor diagnostic standards, and
the lack of clinician confidence in diagnostics currently
available, the disease may be misdiagnosed and individuals
treated unnecessarily with antimalarial agents.
The current World Health Organization (WHO) recommendation is detection of parasites using bright field
microscopy or rapid diagnostic tests (RDTs) before making a diagnosis and implementing treatment [4]. Despite
this, in regions where malaria is endemic, less than half
of the individuals with presumptive malaria will receive
confirmatory testing and will, instead, receive empiric
therapy [3]. Through policy changes and implementation
of RDTs, diagnostic testing has improved, although testing in febrile children is still lacking [5]. Limited access
to appropriate resources, as well as social factors, contribute to the difficulty of diagnosis in patients presenting with symptoms of malaria. This is especially true for
children. Some individuals in resource-limited regions

with febrile illness pursue informal private sector care at
pharmacies, traditional healers, or marketplace therapies
instead of formal medical care. Those who seek care at
local clinics are often treated empirically due to lack of
reliable tests and financial concerns that prohibit transport to government run facilities where these resources
may be present [5, 6]. Often, in remote areas where a
microscope may not even be available, diagnosis is empirical and based solely on clinical features. This approach may lead to overtreatment of malaria, missed
diagnosis or inappropriate treatment of other febrile illnesses, wasting of resources, and development of drug
resistance secondary to selective pressure against the
Plasmodium parasite [4, 7–12]. The reliance on clinical
features to diagnose malaria is consistent with the widespread practice of treating all febrile illness as malaria
based on the presumptive diagnosis in endemic regions
with high prevalence. However, especially in the era of
HIV and the associated opportunistic infections, the
signs and symptoms of malaria may be vague and the
clinical presentation may be limited to a history of fever
[13]. Due to the nonspecific clinical picture, many other
causes of fever should be considered in addition to
malaria [4]. In 2014, D'Acremont et al. showed that the
majority of cases of fever of unknown origin in regions
where malaria is endemic are caused by viral or bacterial
illnesses and not malaria [14]. Despite this, a large majority of individuals continue to receive unnecessary
treatment with antimalarial medications, owing to the
difficulty in changing long-standing clinical habits and
practices. With the possible exception of infants at risk
for cerebral malaria, it is vital to confirm a diagnosis of
malaria prior to treatment. This approach can circumvent futile treatment and reduce the development of
drug resistance, An appropriate diagnostic test is one
that is cost-effective, accurate, and can produce results
within a time frame appropriate to the severity of the
clinical circumstances [4, 15].
Currently, the gold standard for malaria diagnosis is
the use of microscopy-based methods such as bright
field microscopy with Giemsa-stained specimens (GS) or
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by validated RDT when available. However, the lack of
clear policies within some institutions, varied behaviour of
individual clinicians, lack of quality control, and inadequate resources may result in poor outcomes [3]. In
order to ensure accuracy, laboratory technicians must be
properly trained and there must be effective quality control and quality assurance programs in place; however this
is often not possible in our experience [16]. A recent survey suggests that many laboratories in Sub-Saharan Africa
lack quality control and many are not WHO-accredited
[17]. The poor quality of some clinical laboratories leads
to a negative impact on healthcare as a whole, perpetuating misdiagnoses and decreasing clinician and community
confidence in the use of such services. The questionable
reliability of microscopic techniques in the region leads to
decreased utilization of laboratory-based methods. As a
result, millions of individuals with suspected malaria do
not receive the recommended tests prior to therapy [3].
The current study was prompted by observations that
most patients presenting with fever were automatically receiving treatment for malaria. Thus, there was an urgent
need to determine the number of malaria-positive fevers
and evaluate the status of the current testing at the
Bamenda Regional Hospital, which is located in the high
grasslands of the northwest province of Cameroon.
The use of fluorescent-based microscopy techniques can
be superior to GS in terms of sensitivity and have been
successful in detection of Mycobacterium tuberculosis [18].
However, conventional fluorescence microscopy is expensive and requires a costly microscope and technical skill,
making this method impractical in resource-scare regions
[19–21]. In light of this and from our experience, we
elected to evaluate inexpensive LED fluorescent attachments for light microscopes that allow the conversion of a
standard microscope into an epifluorescence microscope
at a fraction of the cost of conventional methods. We
chose the ParaLens AdvanceTM light microscope attachment (QBC Diagnostics, Port Matilda, PA) since it was a
system we recently evaluated against a standard light
microscope for diagnosis of Mycobacterium infections and
observed 100% agreement between both methods [18].
The use of this relatively inexpensive diagnostic system
and staining method has not been applied in cases of malaria to our knowledge. The majority of published studies
using this technique have been directed toward detection
of Mycobacterium species and have shown positive results
and increased sensitivity in comparison to standard
methods [22, 23]. A similar method is available for the detection of malaria infections using parasite-specific stains
such as the Fluorescence and Staining Technologies
(FAST) Malaria stain produced by the company QBC
Diagnostics. This is not to be confused with an alternative
technique in vogue during the 1980s referred to as the
QBC (quantitative buffy coat) test that requires a specific
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centrifuge to separate Plasmodium organisms in capillary
tubes and is, therefore, more expensive. The main advantages of the FAST Malaria stain over GS are that it is presumably less technically complex, faster to perform, can be
used with a relatively inexpensive LED microscopy attachment, obviates the need for a halogen lamp or disposing of
the heavy metals, and may require less training and experience to make an accurate diagnosis. Because of these advantages, such a technique could be employed in developing
countries where malaria is endemic in order to improve
diagnostic accuracy without a large increase in costs.
In the current study, we evaluated the performance of
the FAST Malaria stain and ParaLens AdvanceTM microscope system (FM) in comparison to GS in a prospective
study in Cameroon. Polymerase chain reaction (PCR)
was used to confirm the presence of blood-borne Plasmodium species and as the standard for comparison between the two microscopy methods. The objectives of
this study were to determine the frequency of malaria in
patients presenting with fever and to compare the sensitivity, specificity, negative predictive value (NPV), and
positive predictive value (PPV) of the two basic staining
methods.

Methods
This study was conducted in accordance with the principles outlined in the Helsinki Declaration and ethical approval was received in February 2011 from the University
of Missouri-Kansas City Institutional Review Board (IRB)
and the Cameroon Ministry of Health Regional Hospital
IRB in Bamenda, Cameroon. Training of the technicians
in the FM technique and reagent quality control was executed the week prior to the initiation of the study until
there was less than 10% difference in skill between results
using known semi-quantitative 1+, 2+, and 3++ malaria
control slides. The collection and staining of slides and
samples for PCR were in parallel to routine standard of
care (Giemsa) at the Regional Hospital over an 8-month
period between January and August 2011. Samples spotted
in quadruplicate onto filter paper cards for PCR analysis
were transported by air to the United States in 2012 and
analysed in a blinded fashion at Kansas City University of
Medicine and Bioscience between 2013 and 2014.
Selection criteria and specimen collection

Peripheral blood samples were obtained sequentially
from voluntary participants with a clinical diagnosis of
“suspected malaria infection” at the Ministry of Heath
Regional Hospital in Bamenda, Cameroon. Patients were
referred for phlebotomy if they exhibited the following
clinical signs and symptoms of a malarial infection: fever
(temperature > 38.0 °C) with associated arthralgia, myalgia, headache, abdominal pain, and malaise, or recent
diagnosis of malaria within the past 6 weeks. No changes
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occurred in the standard of care prior to the study. The
blood specimens were collected and slides were prepared
for thin and thick smears, de-identified, and assigned a
sequential identification number. Two additional sets of
thin and thick blood smears were made for each patient
and a drop of blood was collected on FTA™ filter paper
cards (Whatman International Ltd., Maidstone, England)
to be used for confirmatory PCR analysis in our research
laboratory in the United States. Positive controls from
malaria-positive participants were prepared for further
standardization and training.
Microscopy assay

The first set of thin and thick smears were stained with
the FAST Malaria stain kit (427760, QBC Diagnostics
Inc., Port Matilda, PA) and evaluated with the ParaLens
AdvanceTM microscope attachment (QBC Diagnostics
Inc., Port Matilda, PA) at 1000X magnification. The stain
is proprietary and developed specifically to enhance
Plasmodium species and the microscope LED attachment can be charged using sunlight. The second set of
thin and thick smears were stained with the traditional
Giemsa stain (Spectrum Chemicals, Gardena, CA) and
evaluated with bright field microscopy for the presence
of parasites. Thick smears were used for screening first
at 1000X magnification. If parasites were detected using
the thick smears, there was confirmatory examination of
the thin smears at 1000X to detect parasites and life
cycle stage. These two sets of samples were randomized
to prevent sequential reading of the same sample by the
same technologist. The samples were divided randomly
into three unique sets, which were read blind by three
different technicians with differing training and experience levels (technicians A, B, and C). There was no cross
examination of samples between the technicians. Additionally, a randomly selected set of samples was analysed blind by a highly skilled technician (technician D)
using the GS and FM system at the Mezam Polyclinic
HIV/AIDS Treatment Center. To minimize any variability due to potential fluorescence stain fading, all slides
stained with FM were read within 48 h of staining. All
parties were blinded to the results of the microscopy
studies and PCR analysis that was carried out on a later
date. Figure 1 demonstrates the microscopic difference
between both techniques.
Polymerase chain reaction

A two-step nested PCR assay was used to confirm the
results of the microscopy studies. PCR has been shown
to have high sensitivity in the detection of malarial species and was, therefore, chosen to compare the microscopy results [24, 25]. This high level of accuracy was the
basis for our utilization of the technique for validation
of results. Oligonucleotide primers were chosen to
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detect a highly conserved region of the small subunit
ribosomal RNA genes for the genus Plasmodium.
The assay was performed directly from the blood samples preserved on the FTATM filter paper. A 1 mm
punch was taken from the filter paper and washed in
150 μL nuclease- free water for 5 min at room
temperature. The PCR assay was performed within 3 h
of washing. The first nest reaction was performed in a
50 μL reaction vessel using a Phusion Blood Direct PCR
Kit (Thermo Scientific, Waltham, MA) and the primers
rPLU1 and rPLU5, which produce a 1 640 bp amplicon
and serve as the template DNA for the second nest reaction. The second nest was performed at a total reaction
volume of 25 μL using a Phusion® High-Fidelity DNA
Polymerase kit (New England Biolabs, Ipswich, MA) and
the primers rPLU3 and rPLU4, which produced a 240 bp
amplicon. Previous studies have shown reliable results
using these primer sets [26–28].
Statistical analysis

Four technicians analysed the blood smears from 499
patients. The accuracy measures from each technician
for both GS and FM including PPV, NPV, sensitivity,
specificity, and error rate are summarized. Descriptive
statistics such as mean and standard deviation were obtained. A one-tail proportional z-score test was
employed to determine whether PPV, NPV, and error
rates produced by FM were significantly lower than GS.
A P < 0.05 was considered to indicate a statistical significance. Statistical Package for the Social Science (SPSS)
version 23 (IBM SPSS Statistics, Chicago, IL) was used
for the analysis.

Results
There were 522 patients with a presumptive diagnosis of
malaria presented for the study and all provided blood
samples. The ages ranged between 1 month to 92 years
with a mean age of 35.35 years (SD = 19.44). Of the 522
samples, 23 were excluded from the final analysis due to
either poor staining (20 slides), damage (2 slides were accidentally broken), or mislabelling (1 with unclear label).
Two patients were excluded due to concomitant lymphoma, which could not be excluded as the source of the
fever. In this study, 469 patients received therapy irrespective of the laboratory diagnosis (the PCR results were not
known at that time). After final analysis, 30 samples
(6.01%) were positive via PCR as determined by a 240 bp
region corresponding to our primer length. Five of the 30
positive samples (16.67%) were specimens from individuals
under the age of 18. Given that Plasmodium falciparum is
indigenous to this area and the fact that all samples confirmed by PCR were reviewed by two clinical pathologists
and determined to be P. falciparum based upon microscopy, it was not considered cost-effective to further

Parsel et al. Infectious Diseases of Poverty (2017) 6:32

Page 5 of 9

Fig. 1 Comparison of microscopy methods. Panel a displays a positive sample using GS showing a positive red cell by the black arrow. Panel b is
an example of a positive sample using the FM system. The white arrow indicates a trophozoite while the arrowhead indicates a schizont. All images
are at 1000 X magnification

validate the species by additional PCR. To our knowledge,
P. vivax, P. ovale, and P. malariae have not been identified
in this area of Cameroon, as in the South Western coastal
region where more than 85% are P. falciparum [2, 5].
Comparison of the PCR results with the microscopy data
obtained from our clinic in Cameroon revealed a high
level of discrepancy between each of the three technicians
using the GS thick and thin smears. In contrast, more
consistency in diagnostic accuracy was observed with FM,
regardless of technician skill level, when using the PCR results as the diagnostic standard. For the GS samples, there
were 35 false positive and 22 false negative results, while
18 false positive and 22 false negative results were
obtained with FM. Proportional z-score test indicated that
the error rate of GS (error rate = 0.1169) was significantly higher than that of FM (error rate = 0.0802)
with p = 0.0259 (z = 1.95). Both one- and two-tailed
proportional z-score tests were applied showing significance, though due to our prior publication for a
similar study using one-tail z-score, we chose to use
this for reporting statistical significance [18].
Using the PCR analysis to confirm the results using
each method, the PPV and NPV were determined for
both methods. The mean of PPV from Giemsa
(19.62%) and FM (27.99%) methods were significantly
different (z = −3.10, P = 0.001). There was no significant difference of NPV between GS (95.01%) and FM
(95.28%) methods (z = 0.1984, P = 0.42). Both microscopy
methods had identical sensitivities (26.67%); however,
there was an improved specificity using the FM method
(96.21% vs. 92.78% with GS, P = 0.046, z = 1.6826). The
data, including individual technician breakdowns, are
summarized in Table 1.

Discussion
Laboratory accuracy is a necessity in the diagnosis of
malaria, as there is currently a high incidence of

misdiagnosis leading to unnecessary or non-beneficial
treatment of other infections [7, 8, 29]. Studies in Africa
suggests that 50% to 99% of antimalarial agents are prescribed to patients who are unlikely to have malaria [30].
This is especially important in this region of the northwest province of Cameroon where the prevalence appears to be relatively low compared to the low-lying
coastal regions. We were surprised at the low number of
malaria-positive samples based upon our impression
from the number of patients seen in previous years, although this could have been due to seasonal variation
(less rain). The year of the study, 2011, was notable for
less rain and generally fewer cases of “suspected malaria”
presenting at the Regional Hospital and fewer confirmed
malaria cases. Table 2 illustrates the number of patients
with confirmed cases of malaria between 2009 and 2013.
The WHO has expressed concern over the lack of
quality laboratory diagnostic tests in regions where malaria is endemic, which leads to increased financial burden and waste of resources [3]. Whether diagnosis is
empirical or by laboratory confirmation in the form of
microscopy, there is a high level of error, especially with
the use of non-accredited laboratories. Anecdotally, after
interviewing clinicians involved during and after our
study, we found that there is a wide range of clinical
symptoms other than fever to make the diagnosis of
malaria. The low specificity of clinical diagnosis, combined with the insensitive diagnostic tools available,
makes this a problematic method in the treatment and
management of individuals afflicted by malaria or related
diseases.
There are many factors affecting the laboratory diagnosis of malaria using traditional methods that must be
taken into consideration when interpreting a diagnostic
report. In the case of GS, lack of appropriate resources
and training are a key feature [31, 32]. Additionally, early
infections may be associated with false negative results
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Table 1 Summary of the microscopy findings for GS and FM
GS

FM

Techniciana

Nb

PPV, %

NPV, %

Errorsc, %

Sen, %

Spec, %

PPV, %

NPV, %

Errors, %

Sen, %

Spec, %

A

138

13.33

92.59

24.64

33.33

79.37

33.33

93.80

8.70

38.46

92.37

B

226

26.67

96.17

8.41

33.33

94.81

23.08

96.19

7.96

27.27

95.28

C

138

0.00

94.85

6.52

0.00

98.47

0.00

94.66

10.14

0

94.66

D

218

38.46

96.41

7.21

41.67

95.92

55.56

96.48

5.29

41.67

97.96

Mean

19.62

95.01

11.69

27.08

92.14

27.99

95.28

8.02

26.85

95.07

SD

16.62

1.75

8.66

18.48

8.65

23.07

1.27

2.04

18.93

2.30

a

Technicians ordered with increasing experience and training level
b
The total patient number was 499, however three samples were analysed by two technicians yielding the same results leading to a total number of reads of 501
c
Error rate refers to the combination of the false positive and false negative readings in a percentage format

due to low numbers of parasites in the blood, which can
be overlooked [31]. Further, the accuracy of the GS
method as well as alternative microscopy tests may also
be affected by the species of parasite and the stage of the
life cycle [33]. Field studies using microscopy suffer from
reduced accuracy and yield low sensitivity making laboratory diagnosis unreliable and impacting clinician
confidence [7, 34]. The current study was prompted by
the need to determine how frequently malaria was responsible for fever in our sample population, as well as
the anecdotal lack of reliability and accessibility of the
RDTs available in the hospital in 2011. There is an urgent need for a reliable, validated, inexpensive RDT for
malaria to replace more cumbersome techniques. In the
interim, the WHO and the Foundation for Innovative
New Diagnostics have emphasized the importance of a
rapid point of care (POC) test for malaria and the WHO
offers valuable guidance on how to validate RDTs for
local use [4]. At the time of this writing, there are no
Table 2 Confirmed and treated malaria cases at Bamenda
Regional Hospital between 2009 and 2013
Number of cases
2009

2010

2011

2012

2013

January

614

513

452

400

585

February

539

508

523

539

425

March

365

321

324

463

482

April

426

492

475

388

500

May

518

498

426

338

342

June

436

559

435

387

362

July

485

430

484

359

301

August

307

481

322

266

273

September

304

503

596

287

447

October

435

731

637

609

376

November

301

683

514

330

568

December

365

480

400

356

425

Total

5 095

6 199

5 588

4 722

5 086

validated POC RDTs for malaria diagnosis with FDA approval or CE Marking recommended by the WHO.
The detection threshold for GS thick blood smears increases with decreasing technician skill level and quality
of equipment [35]. Even with common equipment and
training, as we found, there is discrepancy in diagnosis
between different laboratories leading to decreased
inter-examiner reliability [36, 37]. Further, specificity of
the test is variable, especially in local laboratories where
training and resources may be inadequate. This may
arise from improper preparation of the slides, as well as
the presence of other organisms or cells appearing similar to Plasmodium species [38].
Our data indicate an increase in the PPV and specificity in the diagnosis of malaria using FM. We found
that FM was faster than GS and that there was significantly less artefactual staining, which could explain
why some of the technicians were able to recognize
the parasites more easily. Our data suggest this increased specificity is less sensitive to the length of
training. The latter finding is important in addressing
problems associated with the diagnosis of malaria, as
the level of technician training is highly correlated
with the use of GS. However, given the low number
of confirmed malaria cases in this study, it is important to evaluate the impact of skill and training on the
GS method in an area with a much higher incidence
of malaria since conventional staining techniques such
as GM and FM are likely to be in use for long into
the future. While technician concordance was not
assessed in this study, there appeared to be increased
reliability with FM when compared with the PCR results. This improved accuracy despite variability in
technician experience using the FM system, if substantiated, could yield improvement in laboratory testing, reduce cost, and reduce the misuse of
medications leading to increased drug resistance.
Employing FM technique to increase the PPV and
specificity in the detection of a Plasmodium infection
could enhance clinician confidence in laboratory data
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and reduce reliance on clinical symptomatology,
which is inherently nonspecific [7–9].
Interestingly, despite the increased sensitivity of FM in
the diagnosis of tuberculosis in a similar format, this was
not observed for malaria in this study [23]. We postulate
this is due to the small number of infected samples and
lack of statistical power to assess for increased sensitivity. As previously described, only 30 samples (6.01%)
were positive via PCR and there were equal numbers of
true positives in both sample sets. This may be coincidental and a larger pool of true positive samples would
be necessary to ascertain differences in sensitivity. Nonetheless, FM shows sensitivity at least equal to that obtained by GS (26.67%) with the potential of less reliance
on technician skill level.
While studies have suggested a prevalence of malaria in
Cameroon ranging from 17.2% to 53.21% over the past
9 years [1], there are large differences between the coastal
areas such as Buea and the high grasslands further north
which varies from year to year depending upon rainfall.
The WHO estimated an incidence of malaria around 25%
for the country as a whole in 2015 [5]. Despite this, we
found a PCR-positive rate of only 6.01%, lending support
for our hypothesis that malaria is over-diagnosed and that
antimalarial medications are over-utilized. While technological error may also have contributed to this finding, this
is unlikely since our assay was robust with positive and
negative controls included to assess the accuracy of the
PCR assay for each patient sample replicated. Further, this
low positive rate confirmed by PCR was within the range
of that seen via microscopy (9.42% for GS and 6.01% for
FM). It is likely that patients negative for a diagnosis of
malaria had unrelated febrile bacterial or viral illnesses, perhaps associated with HIV [8, 9]. Furthermore, despite the low number of confirmed positive
cases, 469 patients were treated with antimalarial
agents. These patients unnecessarily received treatment because they were believed to have the disease.
This further corroborates the lack of sensitivity with
subjective signs and symptoms of malaria and highlights the need for more accurate diagnosis.
Anecdotally, physicians were reluctant not to treat all
patients symptomatically before results were known,
even with the negative test results. Despite this, the preliminary findings in our study led to a policy change at
the Cameroon Ministry of Heath Regional Hospital in
Bamenda in an effort to mitigate these unnecessary
treatments. However, as shown elsewhere, physicians
and allied health personnel practices are resistant to
change [9]. This policy change to promote the use of
microscopy or a validated RDT in place of empirical
treatment of malaria has been implemented following
results of this study but has proved very difficult to enforce as of July 2016.
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Conclusions
This study showed that there was a low number of
malaria-positive patients of those presenting with a presumptive diagnosis of malaria at the Bamenda Regional
Hospital in 2011. We also showed a correlation between
technician training and the accuracy of malaria diagnosis
using bright field microscopy with GS. Differences in
skill level diminished when using the FM system, which
is faster, slightly more specific, had an increased PPV,
and reduced staining artifact compared to standard GS.
However, a significantly low sensitivity of both GS and
FM was present even with highly experienced technicians. This study highlights the need for an inexpensive
diagnostic method with improved reliability and acknowledges the potential for emergence of drug resistance exacerbated by the widespread practice of empirical
treatment for malaria. Public health systems should be
vigilant to encourage improvement in physician prescribing practices. Continued education of technical
personnel is important, as is encouragement in the use
of validated RDTs when resources are available. Finally,
education of the public as to the causes of drug resistance enhanced by self-medication for malaria is important. A larger study to determine and compare the
impact of technical expertise using the two methods in
an area with a higher prevalence of malaria is planned
with the additional objective to compare these methods
against available RDTs and validate our current findings.
Furthermore, it would be worth assessing the concordance in diagnostic accuracy between technicians of varying skill levels on the same samples.
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